Hematology, Oncology, Endocrinology & Infectious Disease – Full Test
Quiz Summary
0 of 48 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
Time has elapsed
Categories
- Endocrine 0%
- Hematology 0%
- ID 0%
- Oncology 0%
- Review / Skip
- Answered
- Correct
- Incorrect
-
Question 1 of 48
1. Question
Hint
Answers: Dabigatran = direct thrombin inhibitor; antidote = idarucizumab (monoclonal antibody). Rivaroxaban = factor Xa inhibitor; antidote = andexanet alfa.
Resource: Pollack et al. NEJM 2015 (RE-VERSE AD — idarucizumab); Connolly et al. NEJM 2016 (ANNEXA-4 — andexanet alfa)
Royal College Competency: 1.3.9, 1.3.9.3, 2.4.7.2 -
Question 2 of 48
2. Question
Hint
a) Onset of action:
– Oral Vitamin K: 6-12 hours (up to 24 hours for full effect)
– IV Vitamin K: 4-6 hours for INR reduction, but faster than oralb) Reason for slow IV administration:
– Rapid IV administration causes anaphylactoid reactions
– Risk of severe hypotension
– Risk of bronchospasm
– Risk of cardiovascular collapse
– Related to vehicle/excipient (polysorbate, polyethoxylated castor oil) not vitamin K itselfCompetency: 1.3.9, 2.4.7.2
Resource: — Ageno W et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl):e44S-e88S -
Question 3 of 48
3. Question
Hint
a) Anaphylactic shock in IgA-deficient patients; acute kidney injury. Additional accepted: hemolytic anemia; anaphylactoid reactions; thromboembolic events; aseptic meningitis; dilutional hyponatremia; transient neutropenia.
Competency: 2.4.11.3; 1.3.9.2
Resource: Darenberg J et al. Clin Infect Dis 2003;37(3):333-340 -
Question 4 of 48
4. Question
Hint
a) Platelets: TTP low, DIC low. LDH: TTP high, DIC high. INR: TTP normal, DIC high. Schistocytes: TTP many, DIC some. Bilirubin: TTP high, DIC high.
Competency: 2.4.7.1; 2.4.7.2; 1.3.2.7
Resource: Levi M, ten Cate H. NEJM 1999;341(8):586-592 -
Question 5 of 48
5. Question
Hint
a) Hemophagocytic lymphohistiocytosis (HLH).
b) Dexamethasone; etoposide.
c) Empiric immunosuppression may mask or worsen an underlying undiagnosed malignancy (e.g. T/NK cell lymphoma) or reactivate an occult infection; yes, initiate treatment given life-threatening multi-organ dysfunction and the clinical urgency of untreated HLH.
d) Adult-onset Still’s disease; T/NK cell lymphoma.
Competency: 2.4.7.1; 1.3.7; 1.3.2.8; 2.2.1; 2.4.11.1
Resource: Shakoory B et al. Arthritis Rheumatol 2023;75(10):1714-1732 (2022 EULAR/ACR Points to Consider for HLH/MAS, PMC11040593); Henter JI et al. Pediatr Blood Cancer 2007;48:124-131 (HLH-2004) -
Question 6 of 48
6. Question
Hint
a) Immune effector cell-associated neurotoxicity syndrome (ICANS); typically occurs with CRS or soon after CRS has resolved.
b) First-line treatment: corticosteroids (dexamethasone or methylprednisolone); severe or refractory ICANS: high-dose corticosteroids. Alternate: anakinra. Tocilizumab is NOT recommended as first-line for isolated ICANS.
c) Pre-existing neurological conditions.
Competency: 2.4.8.6; 2.4.4.2
Resource: Crespo A et al. T-Cell Engaging Antibodies: Management of CRS and ICANS. Ontario Health (Cancer Care Ontario) Clinical Practice Guideline. December 2024 -
Question 7 of 48
7. Question
Hint
a) 1 mark: submassive / intermediate-high risk PE.
b) 1 mark: observation
c) 1 mark: IVC filter.
d) 3 marks: 1 mark each for three. catheter directed thrombectomy*, thrombolysis, surgical embolectomy (not preferred – hemorrhage risk)f) 2 marks — 1 mark each: hypotension; cardiac arrest / shock. g) 1 mark: filter thrombosis.
Competency: 2.4.7.2; 2.4.3.1; 1.3.12.2; 2.4.4.3
Resource: Konstantinides SV et al. ESC Guidelines for acute pulmonary embolism. Eur Heart J 2020;41:543–603; Stein PD et al. Vena cava filters in patients with pulmonary embolism and contraindication to anticoagulation. Am J Med 2007 -
Question 8 of 48
8. Question
Hint
a) 1 mark: hemophagocytic lymphohistiocytosis (HLH).
b) 3 marks — 1 mark each: ferritin >500 (markedly elevated); hypertriglyceridemia; hypofibrinogenemia. Alternate: cytopenias affecting ≥2 lineages; fever.
c) 1 mark: EBV PCR.
d) 1 mark: corticosteroids.Competency: 2.4.7.1; 1.3.7; 1.3.5; 2.2.1
Resource: Henter JI et al. HLH-2004 diagnostic guidelines. Pediatr Blood Cancer 2007;48:124–131; La Rosee P et al. Recommendations for management of HLH in adults. Blood 2019;133:2465–2477 -
Question 9 of 48
9. Question
Hint
Answers: serotonin release assay (SRA) – gold standard. ELISA – detects heparin dependant antibodies (anti PF4) – quite a sensitive test, quite easy to do, but not specific (high false positive rate) – so useful as first screening test. Timing, Thrombocytopenia, Thrombosis, ?any other causes of Thrombocytopenia. Citrate infusion pre filter with calcium infusion post filter (monitor ionized and total calcium). Argatroban infusion (monitor PTT). Note: other options are not appropriate in renal failure (danaparoid/lepirucin). LMWH (dalteparin), but also the pulmonary artery catheter is heparin-bonded and would need to be removed (non-heparin bonded catheters are available). NOTE: there is no heparin in our catheter flush solutions. (See ACCP guidelines for Diagnosis and Rx of HIT).
Resource: Linkins et al. Chest 2012 (ACCP HIT Guidelines); Lo et al. J Thromb Haemost 2006 (4Ts score); Warkentin NEJM 2006
Royal College Competency: 1.3.9, 2.4.7.2, 3.1.9 -
Question 10 of 48
10. Question
Hint
Answers: 1. DIC 2. TTP 3. HIT 4. ITP. Two features: platelet above 50, 3days, no thrombosis, schistocytes support other etiology. Situations: neurosurgical procedure, massive hemorrhage
Resource: Linkins et al. Chest 2012 (ACCP HIT Guidelines); AABB Platelet Transfusion Guidelines 2015; Levi & Hunt JTH 2015 (DIC)
Royal College Competency: 2.4.7.1, 2.4.7.2, 3.1.1 -
Question 11 of 48
11. Question
Hint
Answers: Supportive care, invasive mechanical ventilation prn, report to transfusion services, no role for steroids
Resource: Toy et al. Transfusion 2019 (TRALI consensus update); Kleinman et al. Transfusion 2019
Royal College Competency: 2.4.2.1, 2.4.7.1 -
Question 12 of 48
12. Question
Hint
Answers: TTP, Ddx DIC, HUS, Sepsis, HELLP, htn, sle. Plasma Exchange and steroids (or ritux), no – consumptive process so no indication for platelets
Resource: Scully et al. Br J Haematol 2012 (BSH TTP Guidelines); George & Nester NEJM 2014
Royal College Competency: 2.4.7.1, 2.4.7.2, 3.1.1 -
Question 13 of 48
13. Question
Hint
Answers: Drug-induced thrombocytopenia (piperacillin-tazobactam). Immediate priorities: stop piperacillin-tazobactam, transfuse platelets (plt 8 + life-threatening hemorrhage = absolute indication). CKD effect on platelets: uremic platelet dysfunction — impaired adhesion and aggregation due to accumulated uremic toxins interfering with GP Ib and GP IIb/IIIa receptors.
Resource: George & Aster NEJM 2009 (drug-induced thrombocytopenia); Daugirdas et al. Handbook of Dialysis (uremic platelet dysfunction); AABB Platelet Transfusion Guidelines 2015
Royal College Competency: 1.3.9, 2.4.5, 2.4.7.1 -
Question 14 of 48
14. Question
Hint
TLS, IV rehydration rasburicase (high-risk/established TLS), confirmatory: uric acid
Resource: Cairo & Bishop Br J Haematol 2004 (TLS definition and grading); Coiffier et al. J Clin Oncol 2008 (rasburicase); Howard et al. NEJM 2011 (TLS management) Royal College Competency: 2.4.5.1, 2.4.8.2, 2.4.9.1
-
Question 15 of 48
15. Question
Hint
FFP for INR, fibrinogen, platelet. TRALI. Stop transfusion, report to blood bank, continue IMV supportive care. Diuresis and steroids not indicated for TRALI.
Resource: Toy et al. Transfusion 2019 (TRALI consensus); Kleinman et al. Transfusion 2019; AABB Transfusion Guidelines
Royal College Competency: 2.4.2.1, 2.4.7.1, 2.4.14.3, 3.1.1 -
Question 16 of 48
16. Question
Hint
Sigmoid, PaO₂ 60 ≈ 90%. PaO₂ 40 mmHg ≈ 70–75%. P50 ≈ 26 mmHg adult Hgb. Larger centres have older blood, less 2,3-DPG, leftward shift in curve, less oxygen offloading at tissues. No inotrope. Expected value. SVC sampling lower ScvO2 reflecting cerebral oxygen utilization higher than visceral/lower body from femoral
Resource: West Respiratory Physiology 10th ed.;
Royal College Competency: 1.1.3.2.1; 1.1.3.2.2 -
Question 17 of 48
17. Question
Hint
a) Common complications post allo-SCT:
– Graft-versus-host disease (GVHD) – acute or chronic
– Infection (bacterial, viral, fungal)
– Veno-occlusive disease / sinusoidal obstruction syndrome
– Graft failure or rejection
– Pulmonary complications (pneumonitis, DAH, ARDS)
– Mucositis
– Cytopenia or marrow suppressionb) Most common infectious organism class:
– Viral infectionsc) Specific pathogens by class:
Bacterial:
– Gram-negative bacteria (E. coli, Klebsiella, Pseudomonas)
– Gram-positive bacteria (Staphylococcus, Streptococcus, Enterococcus)Viral:
– Cytomegalovirus (CMV)
– Epstein-Barr virus (EBV)
– Adenovirus
– BK virus
– Respiratory viruses (RSV, influenza, parainfluenza)
– Herpes simplex virus (HSV)
– Varicella zoster virus (VZV)Fungal:
– Aspergillus species
– Candida species
– Pneumocystis jirovecii
– Mucorales speciesCompetency: 2.4.1, 2.4.8, 2.4.11, 2.4.14.3
Resource: Tomblyn M et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients. Biol Blood Marrow Transplant 2009; 15:1143-1238 -
Question 18 of 48
18. Question
Hint
TLS. Excessive purine catabolism → hypoxanthine/xanthine → uric acid via xanthine oxidase. Management: IV hydration, rasburicase (high risk), treat hypokalemia/hypocalcemia, RRT. Rasburicase prophylaxis: high-risk patients.
Resource: Cairo & Bishop Br J Haematol 2004; Coiffier et al. J Clin Oncol 2008 Royal College Competency: 2.4.5, 2.4.8.2, 2.4.9
-
Question 19 of 48
19. Question
Hint
Adrenal insufficiency, metformin toxicity, septic shock. Also myxedema coma, anaphylaxis. AI = hypoglycemia, hyponatremia, hyperkalemia, MAc, hypereosinophilia. Hydrocortisone 100mg
Resource: Annane et al. JAMA 2002 (CORTICUS); Surviving Sepsis Campaign 2021; Cooper & Stewart NEJM 2003
Royal College Competency: 1.3.9, 2.4.1, 2.4.9.3 -
Question 20 of 48
20. Question
Hint
Immediate Priorities: (1) IV levothyroxine – correct hypothyroidism (2) IV fluids and glucose (to address hypoglycemia and hemodynamic instability) (3) treat precipitating factors such as infection or medication effects to prevent further deterioration. Alternate acceptable: hydrocortisone, warming
Hypothermia differential: sepsis, AI, hypopit, Rx (antipsychotics, VPA, BNZ, metformin, trazodone)
Resource: Jonklaas et al. ATA Hypothyroidism Guidelines 2014; Wall et al. Myxedema Coma review
Royal College Competency: 2.4.1, 2.4.9.3 -
Question 21 of 48
21. Question
Hint
Normal or mildly elevated glucose, ketoacidosis, SGLT2 inhibition. Mgmt IV insulin and fluid. Infection, non-compliance, AMI*
Resource: Peters et al. Diabetes Care 2015 (euDKA); Goldenberg et al. Can J Diabetes 2016
Royal College Competency: 1.3.9, 2.4.9.3 -
Question 22 of 48
22. Question
Hint
Answers: Thyrotoxicosis, betablockers and anti-thyroid medication, SIADH from thyrotoxicosis, thyrotoxic encephalopathy.
Resource: Ross et al. ATA Hyperthyroidism Guidelines 2016; Bahn Chair et al. Thyroid 2011
Royal College Competency: 2.4.4.2, 2.4.9.1, 2.4.9.3 -
Question 23 of 48
23. Question
Hint
a) Diagnosis:
– Diabetic ketoacidosis (DKA)b) Diagnostic criteria (any 2):
– Hyperglycemia (glucose >11 mmol/L or >200 mg/dL)
– Metabolic acidosis (pH <7.3 or bicarbonate <15 mmol/L) – Ketonemia or ketonuria – Anion gap >12c) Pathogenesis:
– Absolute or relative insulin deficiency prevents glucose uptake by cells
– Counter-regulatory hormones (glucagon, cortisol, catecholamines, growth hormone) are elevated causing increased hepatic glucose production and glycogenolysis
– Lipolysis is activated releasing free fatty acids which are converted to ketone bodies (beta-hydroxybutyrate, acetoacetate) in the liver causing metabolic acidosis
– Osmotic diuresis from hyperglycemia leads to dehydration, electrolyte losses (potassium, sodium, phosphate)d) Initial management orders:
– IV fluid resuscitation with 0.9% normal saline 1-2 L bolus initially
– Insulin infusion 0.1 units/kg/hour IV after initial fluid resuscitation
– Potassium replacement (10-20 mEq/L in IV fluids) once urine output establishedCompetency: 2.4.9.1, 2.4.9.3
Resource: UNVERIFIED — Kitabchi AE et al. Hyperglycemic crises in adult patients with diabetes. Diabetes Care 2009; 32(7):1335-1343 -
Question 24 of 48
24. Question
Hint
a) SIADH; initial management is water restriction.
b) Cerebral salt wasting misdiagnosed as SIADH; fluid restriction in CSW worsens hypovolaemia and cerebral vasospasm.
c) Central diabetes insipidus (AVP deficiency). injury to hypothalamus; treatment is desmopressin and free water replacement.
d) Osmotic diuresis from mannitol or hyperglycaemia; loop diuretic administration.
Competency: 2.4.9.1; 1.3.2.6; 2.4.4.2
Resource: Overgaard-Steensen C, Ring T. Critical Care 2013;17:206 -
Question 25 of 48
25. Question
Hint
a) Unopposed alpha-adrehergic activity, severe vasoconstriction, hypertension.
b) Unmasked severe hypovolemia; catecholamine-induced cardiomyopathy (Takotsubo); unopposed beta-2 adrenergic-mediated vasodilation. Alternate: reflex tachycardia and catecholamine-induced arrhythmogenesisCompetency: 1.3.2.2; 1.3.2.6; 1.3.9.5; 2.4.3.1; 2.4.9.3
Resource: Lenders JWM et al. Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2014;99(6):1915-1942 -
Question 26 of 48
26. Question
Hint
a) 2 marks (one each): rapid fall in effective osmolality; cerebral edema / raised ICP.
b) 2 marks: 2×132+22 = 286 mOsm/kg; excessive fall
c) 2 marks (one each): hypertonic (3%) saline; discontinue Ringer’s lactate/hypotonic fluids.Competency: 2.4.9.3; 2.4.9.1; 2.4.4.2
Resource: Scott AR; Joint British Diabetes Societies (JBDS) for Inpatient Care. Management of hyperosmolar hyperglycaemic state in adults with diabetes. Diabet Med 2015;32(6):714-724. -
Question 27 of 48
27. Question
Hint
Hypertensive hemorrhage, lymphoproliferative disease, PRES. Nephrotoxicity, metabolic abnormalities (diabetes, dlp, hyperuricemia, hyperkalemia, hypomagnesemia), bone loss, infection, gi upset
Resource: Bechstein Transpl Int 2000; Badalian-Very et al. Transplantation 2007
Royal College Competency: 1.3.9, 2.4.14.3 -
Question 28 of 48
28. Question
Hint
Subclavian site has lowest infection risk, RCTs have shown no benefit to routine change of catheter – recommendations are to remove when no longer required, and to assess daily for any signs of infection/purulence at site, MRSA/VRE/c diff, Ventilator associated pneumonia, Catheter related blood stream infections, Surgical site infection, Use of surgical safety checklist, Hand hygiene compliance, Hospital standardized mortality ratio
Resource: Marik et al. Crit Care Med 2012; CDC CLABSI Guidelines; IDSA CVC Guidelines 2009
Royal College Competency: 2.4.11.4, 3.4.6.3, HA 5.2 -
Question 29 of 48
29. Question
Hint
NSTI. Polymicrobial (GAS, Staph including MRSA, anaerobes). Empiric: imipenem or pip-tazo + clindamycin (inhibits GAS toxin synthesis, growth-phase independent) + vancomycin. Essential non-antibiotic: surgical debridement. Bullous DDx: bullous pemphigus, SJS/TEN, DRESS.
Resource: Stevens et al. IDSA NSTI Guidelines 2014; ATLS 10th ed.
Royal College Competency: 1.3.9.2, 2.4.11 -
Question 30 of 48
30. Question
Hint
Invasive pneumococcal infection or pneumococcal sepsis, MAP, urine output, skin mottling, capillary refill, lactate, CvSaO2
Resource: Surviving Sepsis Campaign 2021; SCCM Sepsis Guidelines
Royal College Competency: 2.4.1, 2.4.11 -
Question 31 of 48
31. Question
Hint
Mucormycosis, amphotericin B, surgical debridement
Resource: Cornely et al. ESCMID/ECMM Mucormycosis Guidelines 2019
Royal College Competency: 1.3.9.2, 2.4.8, 2.4.11 -
Question 32 of 48
32. Question
Hint
a) Management components:
– Trimethoprim-sulfamethoxazole (TMP-SMX) 15-20 mg/kg/day (of TMP component) IV divided q6-8h for 21 days
– Corticosteroids (prednisone 40 mg PO BID × 5 days, then 40 mg daily × 5 days, then 20 mg daily × 11 days) if PaO2 <70 mmHg or A-a gradient >35
– Alternative antibiotics if sulfa allergy: pentamidine IV, clindamycin-primaquine, atovaquone
– Supportive care with mechanical ventilation and oxygenation
– G-CSF if neutropenicb) Prophylaxis alternatives to Septra:
– Atovaquone 1500 mg PO daily
– Dapsone 100 mg PO daily
– Inhaled pentamidine 300 mg monthly via nebulizer
– IV pentamidine monthly (less commonly used)Competency: .3.9.2, 2.4.1, 2.4.11
Resource: Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome. Mayo Clin Proc 1996; 71:5-13 -
Question 33 of 48
33. Question
Hint
a) Airborne infection isolation room with negative pressure; doors and windows kept closed; N95 mask or powered air-purifying respirator (PAPR) for all personnel entering the room.
b) Three consecutive sputum samples on separate days with negative AFB smears.
c) 12 air exchanges per hour for new construction or renovation.Competency: 2.4.11.3; 5.2.1; 3.4.5.5
Resource: Jensen PA et al. MMWR Recomm Rep 2005;54(RR-17):1 -
Question 34 of 48
34. Question
Hint
a) MSSA; community-acquired MRSA; Streptococcus pneumoniae; gram-negative organisms.
b) Linezolid (preferred for pulmonary penetration and toxin inhibition); alternatives: vancomycin plus rifampin; tigecycline.Competency: 2.4.11.1; 2.4.11.3; 1.3.9.2
Resource: Wunderink RG et al. Clin Infect Dis 2012;54(5):621 -
Question 35 of 48
35. Question
Hint
a) Streptococcus pneumoniae; Staphylococcus aureus (MSSA); Escherichia coli; Klebsiella pneumoniae; Serratia marcescens; Enterobacter species. Additional accepted: Proteus mirabilis; Pseudomonas aeruginosa.
Competency: 2.4.2.1; 1.3.9.2
Resource: Kalil AC et al. Clin Infect Dis 2016;63(5):e61-e111 -
Question 36 of 48
36. Question
Hint
a) Voriconazole.
b) Lipid formulation amphotericin B; posaconazole.
c) Echinocandin; azole.Competency: 1.3.9.2; 1.3.5; 2.4.14.2
Resource: Stevens DL et al. IDSA SSTI Guidelines. Clin Infect Dis 2014;59(2):e10-e52 -
Question 37 of 48
37. Question
Hint
a) 2 marks: decreased tacrolimus levels; increase dose / monitor trough.
b) 2 marks: decreased INR / reduced effect; increase warfarin dose / monitor INR closely.
d) 1 mark: biofilm penetration / prosthetic material activity.Competency: 1.3.6; 1.3.9.2; 2.4.11.3
Resource: Baciewicz AM et al. Update on rifampin and rifabutin drug interactions. Am J Med Sci 2008;335:126–136; Habib G et al. ESC Guidelines for endocarditis. Eur Heart J 2015;36:3075–3128 -
Question 38 of 48
38. Question
Hint
Answers: Rabies, PCR of neck, saliva, CSF or serum. UTD
Resource: Rupprecht et al. MMWR 2010 (rabies post-transplant cases); CDC Rabies Guidelines
Royal College Competency: 2.4.11, 2.4.14.3 -
Question 39 of 48
39. Question
Hint
a) 1 mark: prosthetic graft fungal infection.
b) 2 marks: fluconazole or echinocandin; minimum 6 weeks.
c) 1 mark: requires surgical source control / graft management
d) 1 mark: selection pressure for fungal growthCompetency: 1.3.5; 1.3.9.2; 2.4.11.3; 2.2.2
Resource: Pappas PG et al. IDSA Clinical Practice Guideline for Candidiasis. Clin Infect Dis 2016;62:e1–e50; Chiesa R et al. Vascular graft infection. J Vasc Surg 2014 -
Question 40 of 48
40. Question
Hint
a) 1 mark: hyperdynamic distributive septic shock (high CO, low SVR, warm vasodilated physiology)
b) 2 marks — 1 mark each for any 2: microvascular shunting, mitochondrial dysfunction, microvascular thrombosis and endothelial dysfunction
c) 2 marks: Lactate <2mmol/L or 10% reduction per 2h (1 mark); intervention: source control (1 mark). Alternate for second mark: early appropriate antimicrobials; avoid excessive fluid administration that worsens interstitial edema and impairs microvascular oxygen diffusion distance.Competency: 1.3.2.2; 1.3.3.2; 2.4.11.1; 2.4.11.2; 2.2.1
Resource: Prescott HC et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Intensive Care Med 2026. doi:10.1007/s00134-026-08361-1 -
Question 41 of 48
41. Question
Hint
a) 2 marks — 1 mark for agent, 1 mark for rationale: severe penicillin allergy (anaphylaxis) is an absolute contraindication to piperacillin-tazobactam
b) 2 marks: meropenem — Pseudomonas coverage; prior susceptibility documented 4 months ago; safe in penicillin allergy (1 mark); add vancomycin or daptomycin for gram-positive coverage including MRSA given device-related infection (1 mark). Alternate: aztreonam
c) 2 marks: indication — prior documented Candida fungemia during LVAD implant hospitalization plus current device-related sepsis with immunocompromise constitutes high-risk indication for empiric antifungal (1 mark); preferred agent: an echinocandin (e.g. micafungin or caspofungin)
d) 2 marks: the LVAD driveline cannot be removed without an alternative (1 mark); local measure: meticulous wound debridement, irrigation, and sterile dressing of the driveline exit site; initiation of infection control precautions for potential MDR organism (contact precautions, wound culture for sensitivities) (1 mark).Competency: 1.3.5; 1.3.6; 1.3.9.2; 2.4.11.1; 2.4.11.2; 2.4.11.3; 2.4.11.4
Resource: Prescott HC et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2026. Intensive Care Med 2026. doi:10.1007/s00134-026-08361-1; ISHLT Guidelines for Device-Related Infections 2023 -
Question 42 of 48
42. Question
Hint
Microthombi, shedding of glycocalyx, increased vascular permeability, deregulated vasoconstriction of capillary]
Resource: Ince et al. ICM 2016 (sepsis microvascular pathophysiology); Singer NEJM 2016
Royal College Competency: 1.3.8, 2.4.11 -
Question 43 of 48
43. Question
Hint
IV abx within 90d, septic shock at time of VAP, ARDS preceding VAP, >5d hospitalization prior to VAP, acute RRT prior to VAP.
Abx for MDR pseudomonas colistin, aztreonam, tobramycin, amikacin, cefepime, ceftazidime-avibactam, cefadiracol. Duration 7 daysResource: Kalil et al. IDSA VAP/HAP 2016
Royal College Competency: 1.3.9.2, 2.4.11.3 -
Question 44 of 48
44. Question
Hint
Vancomycin, daptomycin, linezolid. Neutropenia, severely ill with sepsis, patients colonized with MDR GNB. Candida RF = prolonged broad spectrum abx, TPN, hematologic malignancy, bone-marrow or solid-organ transplant, femoral line, colonization of candida at multiple sites.
Resource: Pappas et al. IDSA Candida Guidelines 2016; IDSA VAP/HAP 2016
Royal College Competency: 1.3.9.2, 2.4.11 -
Question 45 of 48
45. Question
Hint
Answers: pneumonia (new lung infiltrate plus clinical evidence of infectious origin including new onset fever, leukocytosis, decline in oxygenation or purulent sputum) occurring >48h after endotracheal intubation
Organisms: Stenotrophomonas, enterobacter, staph aureus, pseudomonas, e.coli., klebsiella
His RF are ARDS preceding VAP, 5 or more days of hospitalization prior to VAP, acute RRT prior. Other RF are IV antibiotics within 90d or septic shock at time of VAP.
Prevention = avoid intonation, minimize sedation, daily SAT, daily SBT, early mobilization, minimize secretions above ETT cuff, elevate HOB 30d, do not disrupt ventilator circuit, selective gut decontamination
Resource: Kalil et al. IDSA/SHEA VAP/HAP Guidelines 2016
Royal College Competency: 1.3.9.2, 2.4.11.3, 2.4.11.4, 5.2.1 -
Question 46 of 48
46. Question
Hint
Inhibits bacterial translocation by binding to 50S subunit, MRSA and VRE, serotonin syndrome with MAO inhibitors
Resource: Moellering NEJM 2003 (linezolid); IDSA MRSA Guidelines 2011
Royal College Competency: 1.3.9.2, 2.4.11 -
Question 47 of 48
47. Question
Hint
Meningococcemia, gram negative cocci, Neisseria meningitidis
Resource: Tunkel et al. IDSA Meningitis Guidelines 2004
Royal College Competency: 1.3.5, 2.4.11 -
Question 48 of 48
48. Question
Hint
Sepsis = life-threatening organ dysfunction from dysregulated host response (SOFA ↑≥2). Septic shock = vasopressor to MAP ≥65 + lactate >2 after resuscitation. Organ dysfunction: SOFA ↑≥2. qSOFA: RR >22, SBP <100, altered consciousness.
Resource: Singer et al. JAMA 2016 (Sepsis-3); Seymour et al. JAMA 2016 (qSOFA)
Royal College Competency: 2.4.11.1, 2.4.11.2